Table 4. Timelines and outcome for 15 hospitalized children with nosocomial pandemic (H1N1) 2009, United Kingdom, 2009–2010.
| Patient no. | Age/sex | Duration, d |
Maximum level of care* | Outcome | |
|---|---|---|---|---|---|
| Hospital admission to symptom onset | Symptom onset to receipt of antiviral therapy | ||||
| 16 | 12 y/F | 10 | Not given | 3 | Recovered |
| 17 | 2 y/M | 24 | Not given | 0/1 | Died at home |
| 18 | 4 y/F | 54 | 2† | 0/1 | Recovered |
| 19 | 15 y/M | 11 | 8 | 0/1 | Recovered |
| 20 | 123 d/F | 123‡ | Unknown data | 3 | Died after transfer to another hospital |
| 21 | 1 y/F | 14 | 1 | 0/1 | Recovered |
| 22 | 1 y/M | 6 | 5 | 3 | Recovered |
| 23 | 9 y/M | Unknown (transferred) | 3 | 3 | Recovered |
| 24 | 12 y/M | 14 | Not given | 0/1 | Recovered |
| 25 | 82 d/M | 82‡ | 1 | 3 | Died§ |
| 26 | 64 d/M | 64‡ | Not given | 1 | Recovered |
| 27 | 151 d/M | 151‡ | 3 | 3 | Recovered |
| 28 | 101 d/F | 101‡ | 1 | 3 | Recovered |
| 29 | 41 d/F | 41‡ | 1 | 3 | Recovered |
| 30 | 9 y/F | 12 | 1 | 0/1 | Recovered |
*Level 3 care is given to patients requiring advanced respiratory support alone or basic respiratory support and support for >2 organ systems; this level includes all patients with complex conditions that required support for multiorgan failure (intensive care unit). Level 0 care is given to patients whose care needs can be met through normal ward care. Level 1 care is given to patients at risk for a deteriorating condition or recently relocated from higher levels of care whose needs can be met in an acute-care ward with additional advice and support from the critical-care team. †Oseltamivir was replaced with zanamivir on day 11 because of identification of the H275Y drug-resistant mutation (patient also received acyclovir throughout hospitalization); ‡Inpatient since birth. §Attributed to pandemic (H1N1) 2009.